An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy for Treatment of Metastatic or Locally Advanced and Unresectable Colorectal Cancer and Locally Advanced or Metastatic Non-Small Cell Lung (Excluding Predominant Squamous Cell Histology)
This is an observational study designed to follow patients with metastatic or locally
advanced and unresectable CRC, locally advanced or metastatic NSCLC (excluding predominant
squamous histology) who are receiving Avastin in combination with first-line chemotherapy.
Second-line metastatic CRC patients are also eligible. Patients who started their Avastin
containing therapy <3 months prior to enrollment are eligible.
Study Status: Recruiting
Mary Poloncarz 216-986-4761 firstname.lastname@example.org
Non-Small Cell Lung Cancer
Information provided by:
Study Type: Interventional
Study Design: Cohort, Prospective
Cleveland Clinic Cancer Center
Independence, Ohio 44131
Mary Sugrue, M.D.., Study Director